Health
T cells target broad range of SARS-CoV-2 epitopes, study shows – Drug Target Review
A study has found that T cells combat SARS-CoV-2 by targeting many sites on the coronavirus, not just the Spike protein.
Posted: 29 January 2021 | Victoria Rees (Drug Target Review) | No comments yet
A study has found that T cells combat SARS-CoV-2 by targeting many sites on the coronavirus, not just the Spike protein.
A new study has suggested that T cells combat SARS-CoV-2 by targeting a broad range of sites on the virus, beyond the key sites on the virus’s Spike (S) protein. By attacking the coronavirus from many angles, the body can potentially recognise different SARS-CoV-2 variants. The study was led by scientists…
-
Noosa News19 hours agoNRL finals live updates: Melbourne Storm vs Canterbury Bulldogs — blog, scores and stats
-
General24 hours agoStewards placed hundreds of bets on Tasmanian races, integrity investigation finds
-
General18 hours agoPrince Harry arrives in Kyiv to meet with wounded Ukrainian war veterans
-
Business22 hours agoUS tipped to cut interest rates next week